1-3 of 3
Bing Li
Close
Sort by
Journal Articles

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts

In Young Choi, Jonathan P Ling, Jian Zhang, Eric Helmenstine, Wencke Walter, Panagiotis Tsakiroglou, Riley E Bergman, Céline Philippe, James L Manley, Kevin Rouault-Pierre, Bing Li, Daniel Howard Wiseman, Kiran Batta, Madhu M Ouseph, Elsa Bernard, Benjamin Dubner, Xiao Li, Torsten Haferlach, Anna Koget, Salman Fazal, Tania Jain, Christopher D. Gocke, Amy E DeZern, William Brian Dalton
Journal: Blood Advances
Blood Adv bloodadvances.2023011260.
https://doi.org/10.1182/bloodadvances.2023011260
Published: 2024
Includes: Supplemental data
Journal Articles

Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma

Clinical Trials & Observations
Zhiyu Liang, Ping Li, Liqing Kang, Lili Zhou, Yang Xu, Shiguang Ye, Juan Du, Bing Li, Yiwen Wang, Lei Yu, Wenbin Qian, Aibin Liang
Journal: Blood Advances
Blood Adv (2022) 6 (1): 293–296.
https://doi.org/10.1182/bloodadvances.2021005814
Published: 2022
Includes: Supplemental data
Journal Articles

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

W. Brian Dalton, Eric Helmenstine, Lisa Pieterse, Bing Li, Christopher D. Gocke, Joshua Donaldson, Zhijian Xiao, Lukasz P. Gondek, Gabriel Ghiaur, Ivana Gojo, B. Douglas Smith, Mark J. Levis, Amy E. DeZern
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1192–1196.
https://doi.org/10.1182/bloodadvances.2019001127
Published: 2020
Includes: Supplemental data